Arezou A. Ghazani - Concepedia

Author

Arezou A. Ghazani

Also Known As

A A Ghazani, A. A. Ghazani, A.A. Ghazani, Amendola, Laura M., Arezou A Ghazani, Arezou A. Ghazani, Arezou Ghazani, Arezou A. Ghazani, Arezou A. Ghazani, Biesecker, Leslie G.

Publications

7.8K

Citations

H-Index

Concepts

All Affiliations

Harvard University Dana-Farber Cancer Institute Brigham and Women's Hospital University of Toronto Broad Institute

About

Arezou A. Ghazani is an author at Harvard University specializing in medicine, molecular diagnostics, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.1K
2	Engineering	5	5	5K
3	Biomedical Engineering	4	4	4.9K
4	Public Health	3	3	733
5	Biomolecular Engineering	1	1	117

Arezou A. Ghazani

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells Devika B. Chithrani, Arezou A. Ghazani, Warren C. W. Chan Nano Letters NanoparticlesEngineeringMetal NanoparticlesNanotoxicologyBiomedical Engineering	2006	4.8K
Assessing the Effect of Surface Chemistry on Gold Nanorod Uptake, Toxicity, and Gene Expression in Mammalian Cells Tanya S. Hauck, Arezou A. Ghazani, Warren C. W. Chan Small	2007	687
Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium Laura M. Amendola, Gail P. Jarvik, Michael C. Leo, The American Journal of Human Genetics SequencingMedicineGeneticsNext-generation SequencingGenetic Epidemiology	2016	564
Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine Andrew J. Aguirre, Jonathan A. Nowak, Nicholas D. Camarda, Cancer Discovery	2018	359
Ultrasensitive Clinical Enumeration of Rare Cells ex Vivo Using a Micro-Hall Detector David Issadore, Jaehoon Chung, Huilin Shao, Science Translational Medicine	2012	242
The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine Andrea Garofalo, Lynette M. Sholl, Brendan Reardon, Genome Medicine	2016	178
Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study Ragan Hart, Barbara B. Biesecker, Carrie L. Blout Zawatsky, Genetics in Medicine Genetic TestingClinical Genomic SequencingNext-generation SequencingGenetic EpidemiologyGenomics	2018	154
High Throughput Quantification of Protein Expression of Cancer Antigens in Tissue Microarray Using Quantum Dot Nanocrystals Arezou A. Ghazani, Jeongjin A. Lee, Jesse Klostranec, Nano Letters NanoparticlesEngineeringCancer AntigensColloidal NanocrystalsHigh Throughput Format	2006	117
A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories Julianne O’Daniel, Heather M. McLaughlin, Laura M. Amendola, Genetics in Medicine Genetic TestingSequencingReporting ProcessesMedicineGenetics	2016	84
Sensitive and Direct Detection of Circulating Tumor Cells by Multimarker µ-Nuclear Magnetic Resonance Arezou A. Ghazani, Cesar M. Castro, Rostic Gorbatov, Neoplasia	2012	63

Page 1